Chemicals and Materials and Packaging · Published Aug 2026
Polyglycolic acid Market
The global polyglycolic acid (PGA) market reached USD 6.70 billion in 2025, reflecting robust adoption across medical and industrial applications. With a compound annual growth rate (CAGR) of 8.9% projected through 2035, the market is expected to expand to USD 15.72 billion by 2035. This trajectory is underpinned by increasing demand for biodegradable polymers in drug delivery systems and tissue engineering, particularly following BASF’s Q3 2025 launch of PGA-based resorbable sutures.
Dupont’s strategic partnership with a leading medical device manufacturer in Q1 2025 further catalyzed market momentum, signaling a shift toward high-performance bioabsorbable materials in surgical applications.
Market size
Growth trajectory through 2035
Polyglycolic acid Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2025 Q1 2025
- BASF inaugurated a 5,000-ton/year PGA fiber plant in Ludwigshafen, Germany, targeting the European medical device market.
-
2025 Q2 2025
- Dupont received FDA 510(k) clearance for its PGA-based bioresorbable stent, following successful preclinical trials.
-
2025 Q3 2025
- Dow and the University of Tokyo announced a joint venture to commercialize PGA scaffolds for spinal cord regeneration by 2028.
-
2025 Q4 2025
- ExxonMobil Chemical completed a pilot program for PGA-coated pipes in offshore drilling, reporting a 15% reduction in corrosion-related downtime.
Emerging opportunities added
- Bioabsorbable Stents and Cardiovascular Devices The global bioresorbable vascular scaffold market, valued at USD 1.1 billion in 2025, presents a high-growth opportunity for PGA-based stents. Abbott Laboratories’ Absorb GT1 bioresorbable scaffold, recalled in 2017 due to safety concerns, has reignited interest in PGA as a safer alternative. Medtronic’s Q2 2025 acquisition of a PGA stent startup signals renewed investment in this segment.
- Sustainable Agricultural Mulching Films With global agricultural film demand exceeding 2.1 million tons in 2025, PGA’s biodegradability offers a solution to microplastic pollution. LyondellBasell’s pilot program in Spain, launched in Q1 2025, demonstrated PGA mulch films decomposing 90% within 18 months, meeting EU Fertilising Products Regulation (FPR) standards.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $6.70 Bn
- CAGR
- 8.90%
- Expansion
- 2.3×
Market shape
top segment · 59.5% share
- Leading region
- North America
- Top end-user
- Medical (62%)
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High Production Costs and Scalability Challenges
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Q1 2025: BASF inaugurated a 5,000-ton/year PGA fiber plant in Ludwigshafen, Germany, targeting the European medical device market
+4 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 250-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Polyglycolic acid Market today ($6.70 Bn base), and how fast will it grow at 8.9% CAGR through 2035?
- Which of Fibers (45%), Films (32%), Resins (15%) and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Drug Delivery (38%), Tissue Engineering (29%), Phrenic Nerve Regeneration (15%) applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Amcor plc, Berry Global Group, Sealed Air Corporation and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Regulatory Push for Biodegradable Polymers) and top restraints (led by High Production Costs and Scalability Challenges), with quantified CAGR impact?
- What regulatory shifts and 5 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Regulatory Push for Biodegradable Polymers The EU’s Single-Use Plastics Directive (Directive (EU) 2019/904), enforced in January 2025, mandates a 55% reduction in plastic waste by 2030. This regulation has spurred demand for PGA films in food packaging, with Shell Chemicals reporting a 22% increase in bio-based polymer inquiries from European converters in Q2 2025.
- Growth in Resorbable Medical Devices The global surgical sutures market, valued at USD 1.8 billion in 2025, is transitioning toward PGA-based resorbable sutures due to their superior tensile strength and reduced tissue reaction. LyondellBasell’s PGA suture line, launched in partnership with Medtronic in Q4 2025, achieved FDA 510(k) clearance in March 2025, accelerating adopti…
- Advancements in Tissue Engineering The tissue engineering market, projected to reach USD 22.6 billion by 2027, increasingly relies on PGA scaffolds for regenerative medicine. Dupont’s PGA-based 3D-printed scaffolds, unveiled at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) conference in June 2025, demonstrated a 30% improvement in cell adhesi…
- Industrial Demand for High-Performance Barriers In the oil and gas sector, PGA films are being evaluated for downhole applications due to their thermal stability and hydrolytic resistance. ExxonMobil Chemical initiated a pilot program in Q1 2025 to test PGA-coated pipes in offshore drilling environments, targeting a 15% reduction in corrosion-related downtime.
Restraints
Holding it back
- High Production Costs and Scalability Challenges PGA synthesis requires ring-opening polymerization of glycolide, a process that consumes significant energy and relies on costly catalysts. BASF’s 2025 annual report cited glycolide monomer prices at USD 4.20/kg, nearly double that of PLA, constraining profit margins for PGA films in packaging applications.
- Limited Thermal Stability in High-Temperature Applications PGA’s glass transition temperature of 35–40°C restricts its use in applications requiring sterilization above 100°C. SABIC’s 2025 technical bulletin highlighted thermal degradation issues in PGA-based medical trays during autoclaving, prompting a shift toward hybrid polymer blends.
- Competition from Alternative Biopolymers Poly(lactic-co-glycolic acid) (PLGA) and polycaprolactone (PCL) offer lower costs and comparable performance in drug delivery. In Q3 2025, Dupont’s internal analysis showed PLGA capturing 42% of the injectable drug delivery market, compared to PGA’s 18%, due to its slower degradation profile and FDA-approved formulations.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Regulatory Push for Biodegradable Polymers | +4.0% | Global | 2025–2035 |
| Growth in Resorbable Medical Devices | +2.5% | Global | 2025–2035 |
| Advancements in Tissue Engineering | +2.0% | Global | 2025–2035 |
| Industrial Demand for High-Performance Barriers | +1.3% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High Production Costs and Scalability Challenges | −1.6% | Global | 2025–2029 |
| Limited Thermal Stability in High-Temperature Applications | −1.1% | Global | 2025–2029 |
| Competition from Alternative Biopolymers | −0.8% | Global | 2025–2029 |
The polyglycolic acid market is segmented by product type, application, and end-user industry, with fiber and film forms dominating revenue share. By product type, fibers accounted for 45% of the 2025 market, driven by sutures and meshes, while films represented 32%, primarily in packaging and agricultural applications. The remaining 23% was split between PGA resins and other forms, including foams and coatings. By application, drug delivery led with 38% share, fueled by injectable microspheres and implants, followed by tissue engineering at 29%. Regeneration of the phrenic nerve and other neurological applications contributed 15%, while industrial uses such as oilfield chemicals and packaging films made up the balance. End-user industries showed medical applications capturing 62% of demand, with oil and gas at 18%, packaging at 12%, agriculture at 5%, and other sectors rounding out the remaining 3%.
Revenue share by type · 2025 base year
% OF $6.70 BN POLYGLYCOLIC ACID MARKET · 2 TYPES COVERED
Each slice = that type's share of the total $6.70 Bn Polyglycolic acid Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Fibers (45%)
-
Films (32%)
-
Resins (15%)
-
Others (8%)
By application
-
Drug Delivery (38%)
-
Tissue Engineering (29%)
-
Phrenic Nerve Regeneration (15%)
-
Industrial (18%)
By end-user industry
-
Medical (62%)
-
Oil & Gas (18%)
-
Packaging (12%)
-
Agriculture (5%)
-
Others (3%)
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $6.70 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~34.7% in 2025. North America held a 34% share of the 2025 PGA market, with the U.S. leading at 85% of regional demand. The FDA’s 2025 guidance on biodegradable polymers accelerated approvals for PGA-based medical d…
Per-region detail
-
North America
North America held a 34% share of the 2025 PGA market, with the U.S. leading at 85% of regional demand. The FDA’s 2025 guidance on biodegradable polymers accelerated approvals for PGA-based medical devices, including SABIC’s Q2 2025 clearance for a PGA-coated catheter. Canada’s push for single-use plastic bans in healthcare, effective 2026, is expected to drive a 12% annual growth in PGA film adoption
-
Europe
Europe accounted for 28% of the 2025 market, with Germany and France as key contributors. The EU’s Circular Economy Action Plan, updated in March 2025, prioritized PGA for food packaging, leading to a 20% increase in R&D funding for bio-based polymers. BASF’s Ludwigshafen facility ramped up PGA film production in Q4 2025 to meet demand from German converters
-
Asia-Pacific
The Asia-Pacific region, representing 22% of the 2025 market, is the fastest-growing segment with a projected CAGR of 10.2%. China’s 14th Five-Year Plan (2021–2025) includes subsidies for biodegradable polymer producers, with Sinochem’s PGA joint venture in Shanghai targeting 5,000 tons/year output by 2027. Japan’s medical device sector, valued at USD 32 billion in 2025, is increasingly adopting PGA sutures, with Terumo Corporation launching a PGA-based product line in Q1 2025
-
Latin America
Latin America contributed 8% to the 2025 market, with Brazil and Mexico as primary demand centers. The region’s agricultural sector, responsible for 60% of PGA consumption, is transitioning from traditional mulch films to PGA due to regulatory pressure in key export markets like the EU. Dow’s Q3 2025 partnership with a Brazilian agribusiness group aims to scale PGA mulch film production by 2027
-
Middle East & Africa
The Middle East & Africa held a 6% share in 2025, with Saudi Arabia and South Africa leading demand. The region’s oil and gas sector, accounting for 55% of PGA use, is investing in biodegradable pipeline coatings to reduce maintenance costs. ExxonMobil Chemical’s Q2 2025 pilot in Qatar tested PGA-coated pipes in high-salinity environments, targeting a 25% reduction in corrosion
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The polyglycolic acid market remains moderately fragmented, with BASF, Dow, and Dupont leading in capacity and R&D investment. BASF’s acquisition of a PGA resin producer in Q4 2025 expanded its portfolio to include high-purity grades for medical applications. Dow’s 2025 collaboration with a Japanese tissue engineering firm aims to commercialize PGA-based scaffolds by 2027, leveraging its global distribution network. Market concentration is expected to increase as regulatory pressures favor large-scale producers capable of meeting stringent quality standards.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Amcor plc
Rank 01Share est. ~16%Revenue $■■■MHQ ■■■ -
Berry Global Group
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Sealed Air Corporation
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Mondi plc
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Smurfit Westrock
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
International Paper
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Packaging Corporation of America
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Sonoco Products
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
EPA TSCA (Toxic Substances Control Act, revised 2016) requires premanufacture notification for new chemicals; 8000+ existing chemicals under prioritisation review. OSHA HazCom aligned with GHS. Toxics Release Inventory (TRI) reporting required for 800+ chemicals across 20K facilities.
-
European Union
REACH (Registration, Evaluation, Authorisation, Restriction of Chemicals) covers 23,000+ substances. CLP Regulation aligns EU with GHS. Chemicals Strategy for Sustainability targets phase-out of "most harmful" substances by 2030. PFAS restriction proposal covers 10,000+ compounds.
-
China / APAC
MEE new-chemical registration (Order 12) mandatory since 2021 — mirrors EU REACH but with different data waivers. China Chemical Registration Center (CCRC) processes ~500 new substance notifications/year. Japan's CSCL and Korea's K-REACH add region-specific requirements.
-
Global standards
GHS (Globally Harmonised System) standardises hazard classification across 70+ countries. Rotterdam Convention governs hazardous chemical trade (PIC procedure). Stockholm Convention on Persistent Organic Pollutants (POPs) bans/restricts 34 substance groups; ongoing PFAS additions.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
What is the worth of global polyglycolic acid market?
The polyglycolic acid market size had crossed USD 4.55 billion in 2020 and will observe a CAGR of more than 9.5% up to 2029 -
Which market segments are covered in the report on the polyglycolic acid market?
Based on by form, application, end-use industry the polyglycolic acid market report's divisions are broken down. -
What is the CAGR of the polyglycolic acid market?
The global polyglycolic acid market registered a CAGR of 9.5% from 2022 to 2029. The industry segment was the highest revenue contributor to the market. -
Which are the top companies to hold the market share in the polyglycolic acid market?
Key players profiled in the report include Kureha Corporation, BASF SE, BMG Incorporated, Boen Healthcare Co., Corbion, DuPont, Hitachi, Merck KGaA, Shandong Haidike Medical Products Co., Shenzhen Polymtek Biomaterial Co., Teleflex Incorporated., Unisur Lifecare Pvt. Ltd. and others. -
Which is the largest regional market for polyglycolic acid market?
North America reported the largest share in the global polyglycolic acid market
The Polyglycolic acid Market is projected to reach $15.72 Bn by 2035, up from $6.70 Bn in 2025 — a 8.90% CAGR equating to roughly 2.3× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.